EDIT - Editas Medicine GAAP EPS of -$0.78 beats by $0.06 revenue of $6.36M beats by $2.07M August, 03 2022 06:30 AM Editas Medicine Inc. Editas Medicine press release ( NASDAQ: EDIT ): Q2 GAAP EPS of -$0.78 beats by $0.06 . Revenue of $6.36M (+1573.7% Y/Y) beats by $2.07M . For further details see: Editas Medicine GAAP EPS of -$0.78 beats by $0.06, revenue of $6.36M beats by $2.07M